Detalhe da pesquisa
1.
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis.
Blood
; 143(14): 1399-1413, 2024 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38194688
2.
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making.
Br J Haematol
; 204(4): 1523-1528, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38070128
3.
Communicating the diagnosis of a hematological neoplastic disease to patients' minor children: a multicenter prospective study.
Oncologist
; 2024 May 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38775839
4.
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.
Blood
; 139(5): 717-731, 2022 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34657149
5.
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Blood
; 140(17): 1845-1857, 2022 10 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35917453
6.
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape.
Ann Hematol
; 103(5): 1561-1568, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38321229
7.
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38722621
8.
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia.
J Cell Mol Med
; 27(20): 3053-3064, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37654003
9.
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.
Hematol Oncol
; 41(1): 128-138, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36265128
10.
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia.
Eur J Haematol
; 110(4): 354-361, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36480004
11.
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study.
Am J Hematol
; 98(11): 1762-1771, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37647134
12.
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study.
Br J Haematol
; 197(2): 190-200, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35137397
13.
IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma.
Blood
; 136(14): 1657-1669, 2020 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32573700
14.
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Hematol Oncol
; 40(5): 846-856, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35854643
15.
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success.
Am J Hematol
; 97(8): 1075-1085, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35384030
16.
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.
Haematologica
; 106(6): 1693-1704, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32327503
17.
Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome-positive leukemia resistant or intolerant to prior therapy.
Eur J Haematol
; 106(6): 808-820, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33638218
18.
Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic-phase CML in clinical practice: 3-year European SIMPLICITY data.
Eur J Haematol
; 106(1): 82-89, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-32989776
19.
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.
Blood
; 132(4): 393-404, 2018 07 26.
Artigo
Inglês
| MEDLINE | ID: mdl-29567798
20.
Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia.
Ann Hematol
; 99(6): 1241-1249, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32307568